Fresenius Kabi Limited

Information

Name

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

http://www.fresenius-kabi.co.uk

Address

Runcorn

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Fresenius Kabi Limited
Sign up free

Contracts awarded to Fresenius Kabi Limited

The contracts that Fresenius Kabi Limited have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 6 months ago

YHPPC - Unlicensed Parenteral Nutrition (PN)

Framework Agreement for Unlicensed Parenteral Nutrition (PN)

£20,000,000 Bids close: 1 year ago
Award

Published 6 months ago

Framework Agreement for the Supply of Unlicensed Parenteral Nutrition (PN) direct award; mini competition or a combination to Trusts within NEYPPC

Framework Agreement for the Supply of Unlicensed Parenteral Nutrition (PN) direct award; mini competition or a combination to Trusts within the North East & Yorkshire NHS Pharmaceuticals Purchasing Consortium.

£120,000,000
Award

Published 7 months ago

NP36124 Antibiotic, Antiviral & Genito Urinary Medicines

Supply of Antibiotic, Antiviral & Genito Urinary Medicines to NHS Scotland.

£29,647,268
Award

Published 7 months ago

NHS National Generic Pharmaceuticals Wave 14c

NHS National Generic Pharmaceuticals- Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

£219
Award

Published 7 months ago

CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024

Project Title: NHS National Framework for Tocilizumab - March 2024 Offer reference number: CM/PHR/23/5702 CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

£46,600,000 Bids close: 10 months ago
Award

Published 7 months ago

NHS National Framework for Tocilizumab - March 2024

Project Title: NHS National Framework for Tocilizumab - March 2024 Offer reference number: CM/PHR/23/5702 CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

£2

Contacts

[email protected]

+44 1928533522

View all 4 contacts, free!

Statistics (1 Year)

Contracts Won

Total Won

£125,028,156

Average Win

£17,861,165

Fresenius Kabi Limited

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Fresenius Kabi Limited

YHPPC - Unlicensed Parenteral Nutrition (PN)

Framework Agreement for the Supply of Unlicensed Parenteral Nutrition (PN) direct award; mini competition or a combination to Trusts within NEYPPC

NP36124 Antibiotic, Antiviral & Genito Urinary Medicines

NHS National Generic Pharmaceuticals Wave 14c

CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024

NHS National Framework for Tocilizumab - March 2024

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win